These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22104283)

  • 21. VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG.
    Saban MR; Davis CA; Avelino A; Cruz F; Maier J; Bjorling DE; Sferra TJ; Hurst RE; Saban R
    BMC Physiol; 2011 Nov; 11():16. PubMed ID: 22059553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.
    Shen Y; Zeng L; Novosyadlyy R; Forest A; Zhu A; Korytko A; Zhang H; Eastman SW; Topper M; Hindi S; Covino N; Persaud K; Kang Y; Burtrum D; Surguladze D; Prewett M; Chintharlapalli S; Wroblewski VJ; Shen J; Balderes P; Zhu Z; Snavely M; Ludwig DL
    MAbs; 2015; 7(5):931-45. PubMed ID: 26073904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular Endothelial Growth Factor-A Increases the Aqueous Humor Outflow Facility.
    Fujimoto T; Inoue T; Maki K; Inoue-Mochita M; Tanihara H
    PLoS One; 2016; 11(9):e0161332. PubMed ID: 27584577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.
    Finley SD; Popel AS
    AAPS J; 2012 Sep; 14(3):500-9. PubMed ID: 22547351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF.
    Neufeld G; Kessler O; Herzog Y
    Adv Exp Med Biol; 2002; 515():81-90. PubMed ID: 12613545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.
    Castro-Rivera E; Ran S; Thorpe P; Minna JD
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11432-7. PubMed ID: 15273288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.
    Gaddy TD; Wu Q; Arnheim AD; Finley SD
    PLoS Comput Biol; 2017 Dec; 13(12):e1005874. PubMed ID: 29267273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.
    Man XY; Yang XH; Cai SQ; Yao YG; Zheng M
    Mol Med; 2006; 12(7-8):127-36. PubMed ID: 17088944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.
    Wu FTH; Stefanini MO; Gabhann FM; Popel AS
    Methods Enzymol; 2009; 467():461-497. PubMed ID: 19897104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex receptor-ligand dynamics control the response of the VEGF system to protease injury.
    Forsten-Williams K; Kurtagic E; Nugent MA
    BMC Syst Biol; 2011 Oct; 5():170. PubMed ID: 22014244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling.
    Kumar BN; Rajput S; Dey KK; Parekh A; Das S; Mazumdar A; Mandal M
    BMC Cancer; 2013 Jun; 13():273. PubMed ID: 23731702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.
    Le XF; Mao W; Lu C; Thornton A; Heymach JV; Sood AK; Bast RC
    Cell Cycle; 2008 Dec; 7(23):3747-58. PubMed ID: 19029832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
    Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
    PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF inhibitors in cancer therapy.
    Cardones AR; Banez LL
    Curr Pharm Des; 2006; 12(3):387-94. PubMed ID: 16454752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
    Saban MR; Sferra TJ; Davis CA; Simpson C; Allen A; Maier J; Fowler B; Knowlton N; Birder L; Wu XR; Saban R
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1245-56. PubMed ID: 20861073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.